U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07404735) titled 'A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846' on Jan. 29.
Brief Summary: A Clinical trial to compare and evaluate evaluate the pharmacokinetics and safety of CKD-846
Study Start Date: Feb. 23
Study Type: INTERVENTIONAL
Condition:
Benign Prostate Hypertrophy(BPH)
Intervention:
DRUG: CKD-846
once administration of Investigational Product
DRUG: D091
once administration of Investigational Product
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Chong Kun Dang Pharmaceutical
Disclaimer: Curated by HT Syndication....